EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer

Yerim Kim, Jae-Hoon Lee, Eun-Suk Cho, Hye Sun Lee, Su-Jin Shin, Eun Jung Park, Seung Hyuk Baik, Kang Young Lee, Jeonghyun Kang iD

Journal of Cachexia, Sarcopenia and Muscle · 2023-04 · 14 (2) · 860-868

DOI: 10.1002/jcsm.13183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 25.01.2023. Verfasst von Yerim Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yonsei University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Sarcopenia, Colorectal Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea (NRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myosteatosis and systemic inflammation are well‐known prognostic factors in patients with colorectal cancer (CRC). The serum albumin level is a reflection of malnutrition and systemic inflammation, which in turn plays a key role in the development of myosteatosis. However, few studies have been conducted on these synergistic effects. This study aimed to examine the individual and synergistic effects of different prognostic markers related to skeletal muscle quality and serum albumin levels in patients with CRC.

Methods

This study enrolled patients with stage I–III CRC who underwent surgical resection between July 2006 and February 2014. Skeletal muscle index (SMI) and skeletal muscle radiodensity (SMD) were calculated using computed tomography at the L3 level obtained within 2 months prior to surgery. The albumin‐myosteatosis gauge (AMG) was defined as SMD × albumin. Patients were divided into sex‐specific quartiles (G1 to G4) according to the AMG, and analysis of variance for continuous variables and chi‐square test for categorical variables were used to compare variables among quartiles. Cox proportional hazard models were constructed and integrated receiver operating characteristic curve (iAUC) analysis was used to compare the prognostic performance of SMD, albumin and AMG.

Results

Among the 906 participants, the median (interquartile) age was 64 (55–72) years, and 365 (40.3%) were female. AMG was significantly correlated with the occurrence of complications, albumin level, SMI and SMD (all P < 0.001). Overall survival (OS) differed significantly according to the AMG group, with 5‐year OS for G1–G4 being 73.4%, 86.2%, 91.1% and 95.5%, respectively ( P < 0.0001). Although SMI, SMD, albumin and AMG were all significant individual prognostic markers of OS in the univariable analysis, AMG remained the only independent prognostic factor in the multivariable analysis (G1 vs. G2, P = 0.045, G1 vs. G3, P = 0.005, G1 vs. G4, P < 0.001, respectively). The iAUC value of AMG [0.681, 95% confidence interval (CI) = 0.638–0.723] was superior to that of SMD (0.610, 95% CI = 0.566–0.654) (bootstrap iAUC mean difference = 0.071, 95% CI = 0.034–0.106), SMI (0.551, 95% CI = 0.511–0.594) (bootstrap iAUC mean difference = 0.129, 95% CI = 0.076–0.181) and albumin (0.627, 95% CI = 0.585–0.668) (bootstrap iAUC mean difference = 0.053, 95% CI = 0.010–0.098).

Conclusions

In patients with stage I–III CRC, AMG is a meaningful predictor of survival, with superior prognostic value compared to SMI, SMD or albumin alone. Further studies are needed to determine their significance in different ethnic groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaColorectal NeoplasmsMaleHumansFemaleMiddle AgedAgedPrognosisRisk FactorsInflammationSerum Albumin

Stichwörter der Autor:innen

albuminalbumin-myosteatosis gaugecolorectal cancerinflammationmyosteatosissarcopenia

Substanzen

Serum Albumin

Autor:innen und Institutionen

  • Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Nuclear Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Jeonghyun Kang

Förderung

  • National Research Foundation of Korea (NRF)

Zitieren

APA

Kim, Y., Lee, J. H., Cho, E. S., Lee, H. S., Shin, S. J., Park, E. J., Baik, S. H., Lee, K. Y., & Kang, J. (2023). Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer. Journal of Cachexia, Sarcopenia and Muscle, 14(2), 860-868. https://doi.org/10.1002/jcsm.13183

Vancouver

Kim Y, Lee JH, Cho ES, Lee HS, Shin SJ, Park EJ, et al. Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer. Journal of Cachexia, Sarcopenia and Muscle. 2023;14(2):860-868. doi:10.1002/jcsm.13183

BibTeX
@article{Kim2023,
  author = {Kim, Yerim and Lee, Jae-Hoon and Cho, Eun-Suk and Lee, Hye Sun and Shin, Su-Jin and Park, Eun Jung and Baik, Seung Hyuk and Lee, Kang Young and Kang, Jeonghyun},
  title = {Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2023},
  volume = {14},
  number = {2},
  pages = {860--868},
  doi = {10.1002/jcsm.13183}
}
Kostenlos starten →